Roche Holding AG (RHHVF)
OTCMKTS
· Delayed Price · Currency is USD
383.46
-11.73 (-2.97%)
At close: Dec 5, 2025
Roche Holding AG Revenue
Roche Holding AG had revenue of 31.85B CHF in the half year ending June 30, 2025, with 4.03% growth. This brings the company's revenue in the last twelve months to 63.49B, up 4.80% year-over-year. In the year 2024, Roche Holding AG had annual revenue of 62.40B with 3.23% growth.
Revenue (ttm)
63.49B CHF
Revenue Growth
+4.80%
P/S Ratio
4.14
Revenue / Employee
614.90K CHF
Employees
103,249
Market Cap
330.43B USD
Revenue Chart
* This company reports financials in CHF.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 62.40B | 1.95B | 3.23% |
| Dec 31, 2023 | 60.44B | -5.37B | -8.16% |
| Dec 31, 2022 | 65.81B | -36.00M | -0.05% |
| Dec 31, 2021 | 65.85B | 5.51B | 9.13% |
| Dec 31, 2020 | 60.34B | -3.41B | -5.35% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Veradigm | 588.02M |
| Elite Pharmaceuticals | 122.89M |
| Glass House Brands | 196.17M |
| American Oncology Network | 1.76B |
| Northwest Biotherapeutics | 937.00K |
| Silence Therapeutics | 25.83M |
| Global Cord Blood | 196.10M |
| Mid-Atlantic Home Health Network | 27.00M |
Roche Holding AG News
- 11 hours ago - Roche May Be Riding A Bit Too High, But Remains Interesting - Seeking Alpha
- 1 day ago - Orano Med Enters Next Phase of Collaboration With Roche - Business Wire
- 4 days ago - Wall Street Just Woke Up to Roche--Here's Why It Could Be Pharma's Next $10 Billion Breakout - GuruFocus
- 4 days ago - Roche (RHHBY) Shares Surge on Promising Drug Developments - GuruFocus
- 4 days ago - Roche shares hit milestone with 19% November surge on breast cancer and promising MS drug trials - Seeking Alpha
- 5 days ago - Roche - Despite Some Study Setbacks, Pipeline Gives Me Increasing Confidence - Seeking Alpha
- 10 days ago - The Zacks Analyst Blog Highlights Alphabet, Roche, RTX, Crawford United and C&F Financial - Nasdaq
- 11 days ago - Top Stock Reports for Alphabet, Roche & RTX - Nasdaq